Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Champions Oncology (CSBR) Equity Ratio (2016 - 2026)

Champions Oncology has reported Equity Ratio over the past 16 years, most recently at 0.15 for Q1 2026.

  • For Q1 2026, Equity Ratio fell 15.68% year-over-year to 0.15; the TTM value through Jan 2026 reached 0.15, down 15.68%, while the annual FY2025 figure was 0.12, 260.14% up from the prior year.
  • Equity Ratio for Q1 2026 was 0.15 at Champions Oncology, up from 0.14 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.28 in Q1 2022 and troughed at 0.08 in Q1 2024.
  • A 5-year average of 0.12 and a median of 0.14 in 2023 define the central range for Equity Ratio.
  • Biggest five-year swings in Equity Ratio: plummeted 153.9% in 2024 and later surged 969.84% in 2025.
  • Year by year, Equity Ratio stood at 0.25 in 2022, then plummeted by 98.7% to 0.0 in 2023, then soared by 720.86% to 0.03 in 2024, then skyrocketed by 419.91% to 0.14 in 2025, then rose by 7.33% to 0.15 in 2026.
  • Business Quant data shows Equity Ratio for CSBR at 0.15 in Q1 2026, 0.14 in Q4 2025, and 0.12 in Q3 2025.